Neoplasm Staging
"Neoplasm Staging" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Methods which attempt to express in replicable terms the extent of the neoplasm in the patient.
| Descriptor ID |
D009367
|
| MeSH Number(s) |
E01.789.625
|
| Concept/Terms |
Neoplasm Staging- Neoplasm Staging
- Staging, Neoplasm
- Tumor Staging
- Staging, Tumor
- Cancer Staging
- Staging, Cancer
TNM Staging- TNM Staging
- Staging, TNM
- TNM Staging System
- Staging System, TNM
- Staging Systems, TNM
- System, TNM Staging
- Systems, TNM Staging
- TNM Staging Systems
- TNM Classification
- Classification, TNM
- Classifications, TNM
- TNM Classifications
|
Below are MeSH descriptors whose meaning is more general than "Neoplasm Staging".
Below are MeSH descriptors whose meaning is more specific than "Neoplasm Staging".
This graph shows the total number of publications written about "Neoplasm Staging" by people in this website by year, and whether "Neoplasm Staging" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 8 | 8 | | 1997 | 0 | 11 | 11 | | 1998 | 2 | 11 | 13 | | 1999 | 1 | 7 | 8 | | 2000 | 0 | 16 | 16 | | 2001 | 2 | 13 | 15 | | 2002 | 0 | 15 | 15 | | 2003 | 1 | 14 | 15 | | 2004 | 1 | 15 | 16 | | 2005 | 5 | 20 | 25 | | 2006 | 0 | 30 | 30 | | 2007 | 0 | 25 | 25 | | 2008 | 0 | 35 | 35 | | 2009 | 0 | 25 | 25 | | 2010 | 3 | 40 | 43 | | 2011 | 1 | 36 | 37 | | 2012 | 1 | 33 | 34 | | 2013 | 4 | 55 | 59 | | 2014 | 1 | 59 | 60 | | 2015 | 2 | 66 | 68 | | 2016 | 4 | 57 | 61 | | 2017 | 2 | 86 | 88 | | 2018 | 3 | 59 | 62 | | 2019 | 5 | 66 | 71 | | 2020 | 2 | 41 | 43 | | 2021 | 0 | 33 | 33 | | 2022 | 1 | 25 | 26 | | 2023 | 0 | 24 | 24 | | 2024 | 4 | 32 | 36 | | 2025 | 1 | 38 | 39 | | 2026 | 0 | 33 | 33 |
To return to the timeline, click here.
Below are the most recent publications written about "Neoplasm Staging" by people in Profiles.
-
Horiike A, Wakui H, Sugawara S, Minegishi Y, Tasaka S, Kusumoto S, Sakatani T, Suzuki H, Hosomi Y, Tambo Y, Shimokawa T, Ishida H, Miyauchi E, Naoki K, Fukuhara T, Mura E, Tsurui T, Suzuki R, Iriguchi N, Ishiguro T, Hirasawa Y, Manabe R, Shimokawa M, Ohkuma R, Ariizumi H, Kubota Y, Hamada K, Takenoshita S, Ryu K, Sambe T, Inoue E, Wada S, Yoshimura K, Sagara H, Kobayashi S, Tsunoda T. Efficacy and Safety of Necitumumab and Pembrolizumab Combination Therapy in Advanced Non-Small Cell Lung Cancer with =50% PD-L1 Expression: A Nonrandomized Phase II Trial. Clin Cancer Res. 2026 Oct 15; 32(20):4571-4579.
-
Zhang BX, Sella T, Zheng Y, Kirkner GJ, Ruddy KJ, Rosenberg SM, Borges VF, Schapira L, Come SE, Peppercorn JM, Collins L, Partridge AH, Brantley KD. Delays in breast cancer presentation, diagnosis, and treatment in young women. Cancer. 2026 Oct 15; 132(20):e70594.
-
Nader-Marta G, Zheng Y, Rosenberg SM, Dibble KE, Mayer EL, Poorvu PD, Ruddy KJ, Guzman-Arocho YD, Collins LC, Peppercorn J, Schapira L, Valenza C, Borges VF, Tayob N, Come SE, Warner E, Polyak K, Winer EP, Partridge AH. Pregnancy history, recency of childbirth, and outcomes in young women with early-stage breast cancer. J Natl Cancer Inst. 2026 Oct 01; 118(10):1933-1941.
-
Evageliou NF, Renfro LA, Vallance KL, Varela CR, Benedetti DJ, Cost NG, Ehrlich PF, Kalapurakal JA, Khanna G, Aldrink JH, Glick RD, Ortiz MV, Parsons LN, Paulino AC, Artunduaga M, Smith EA, Dix DB, Fernandez CV, Dome JS, Geller JI, Mullen EA. Impact of post-chemotherapy classification on outcomes in stage III and IV unilateral favorable histology Wilms tumor: Pooled data from Children's Oncology Group AREN0532, AREN0533, and AREN03B2 studies. Cancer. 2026 Oct 01; 132(19):e70610.
-
Kassamali B, Schoenfeld JD, Sethi R, Bakst RL, Barker CA, Bhatt AA, Bradford CR, Bunch PM, Carr DR, Carucci JA, Chandra S, Chen M, Connolly KL, Demer AM, Doonan B, Emerick K, Friedman BJ, Gali LL, Galloway TJ, Geiger JL, Guenette JP, Kelly HR, Khushalani NI, Kohen L, Koyfman S, Kumar SS, Learned KO, Leitenberger JJ, Lilley EJ, Lukens JN, Medina T, Mitra D, Ozog D, Pashtan I, Patel VA, Pham N, Powers MC, Srivastava D, Swiecicki PL, Taylor CS, Witek ME, Wysong A, Zander D, Silk AW, Jambusaria-Pahlajani A, Ruiz ES. Consensus Guidelines for Staging and Surveillance Imaging in Cutaneous Squamous Cell Carcinoma. JAMA Dermatol. 2026 Sep 01; 162(9):939-947.
-
Isaacs C, Nanda R, Yau C, Chien AJ, Hershman DL, Stringer-Reasor EM, Wallace AM, Thomas A, Vaklavas C, Clark AS, Kennedy LC, Sanford A, Boughey JC, Albain KS, Pusztai L, Kalinsky KM, Beckwith H, Williams NO, Han HS, Falkson C, Arora M, Elias AD, Pohlmann PR, Rozenblit M, Marshall N, Chen YY, Trivedi MS, McGuinness JE, Howard FM, Chen N, Khoury K, Lancaster RB, Yeung KT, Douglas E, Wei M, Mainor C, LeStage B, Delson AL, Asare AL, Brown-Swigart L, Hirst GL, Matthews JB, Perlmutter J, Symmans WF, Yee D, Hylton NM, van 't Veer LJ, Rugo HS, DeMichele AM, Berry DA, Esserman LJ. Cemiplimab and Fianlimab With Neoadjuvant Chemotherapy in Early-Stage High-Risk ERBB2-Negative Breast Cancer: The I-SPY2 Randomized Clinical Trial. JAMA Oncol. 2026 Sep 01; 12(9):1008-1017.
-
Flerlage JE, Eichenauer DA, Fuchs M, Hartmann S, Eich HT, Savage KJ, Lo AC, Skinnider B, Akhtar S, Rauf MS, Maghfoor I, Pinnix CC, Steiner R, Milgrom SA, Vega F, Alomari M, Zhang XY, Collins GP, Advani RH, Kumar P, Dickinson M, Wirth A, Tsang R, Prica A, Major A, Smith S, Hendrickson PG, Kelsey CR, Hopkins D, McKay P, Ng A, Koenig J, Constine LS, Casulo C, Sakthivel G, Baron J, Plastaras JP, Roberts KB, Gao S, Al Kendi J, Al Rahbi N, Balogh A, Levis M, Ricardi U, Sridhar A, Torka P, Specht L, De Silva R, Shah N, Pickard K, Osborne W, Blazin LJ, Henry M, Chang I, Smith CM, Halperin D, Miall F, Brady JL, Mikhaeel G, Brennan B, Penn A, Senchenko MA, Volchkov EV, Reeves M, Hoppe B, Terezakis S, Talaulikar D, Della Pepa R, Picardi M, Kirova Y, Fergusson P, Northend M, Hawkes E, Lee D, Doo NW, Barraclough A, Opat S, Cheah CY, Salvaris R, Ku M, Hamad N, Mutsando H, Tedjaseputra A, Gilbertson M, Marconi T, Viiala N, Palese M, Shankar A, Maurer MJ, Natkunam Y, Kelly KM, Borchmann P, Hoppe RT, Binkley MS. Historical outcomes for patients with stage IA NLPHL: Global NLPHL One Working Group retrospective analyses. Blood Adv. 2026 08 11; 10(15):5338-5347.
-
Kaddas HK, Ou JY, Alonzo T, Spector LG, Fallahazad N, Owens E, Kirchhoff AC, Green AL. Sociodemographic Factors Associated With Later Stage at Diagnosis of Pediatric Germ Cell Tumors: A Report From Children's Oncology Group Registries ACCRN07 and APEC14B1. Pediatr Blood Cancer. 2026 Oct; 73(10):e70562.
-
Mullen EA, Renfro LA, Ehrlich PF, Khanna G, Gratias EJ, Cost NG, Parsons LN, Grundy PE, Fernandez CV, Geller JI, Dome JS. Concordance Between Institutional and Central Pathology, Surgery, and Radiology Reviews on the Children's Oncology Group AREN03B2 Renal Tumor Biology and Classification Study. Pediatr Blood Cancer. 2026 Oct; 73(10):e70515.
-
Oselinsky KM, Hill EB, Ostendorf DM, Pan Z, Bing K, Wayland LT, Simpson C, Clark KC, Sandoval A, Thomas EA, Marker RJ, Kabos P, MacLean PS, Catenacci VA. Exploring the Feasibility, Acceptability, and Safety of a 4:3 Intermittent Fasting Weight Loss Program Among Stage I-III Breast Cancer Survivors With Overweight or Obesity: Protocol for a 6-Month Proof-of-Concept Feasibility Trial. JMIR Res Protoc. 2026 07 23; 15:e86281.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|